Use of the human eosinophilic cell line EoL-1 to investigate the molecular mechanisms regulating cyclin-dependent kinase inhibitor drug-induced apoptosis

A. L. Alessandri; L. Hoodless; Christopher Lucas; J. F. Lyons; C. Haslett; R. Duffin; A. G. Rossi

Use of the human eosinophilic cell line EoL-1 to investigate the molecular mechanisms regulating cyclin-dependent kinase inhibitor drug-induced apoptosis

A. L. Alessandri, L. Hoodless, Christopher Lucas, J. F. Lyons, C. Haslett, R. Duffin, A. G. Rossi

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	261-261
Number of pages	1
Journal	Immunology
Volume	137
Publication status	Published - Sept 2012
Event	European Congress of Immunology - Glasgow Duration: 5 Sept 2012 → 8 Sept 2012

Cite this

@article{b3d9daafccd2470dad539827b127cc5f,

title = "Use of the human eosinophilic cell line EoL-1 to investigate the molecular mechanisms regulating cyclin-dependent kinase inhibitor drug-induced apoptosis",

author = "Alessandri, {A. L.} and L. Hoodless and Christopher Lucas and Lyons, {J. F.} and C. Haslett and R. Duffin and Rossi, {A. G.}",

year = "2012",

month = sep,

language = "English",

volume = "137",

pages = "261--261",

journal = "Immunology ",

issn = "0019-2805",

publisher = "Wiley-Blackwell",

note = "European Congress of Immunology ; Conference date: 05-09-2012 Through 08-09-2012",

}

TY - JOUR

T1 - Use of the human eosinophilic cell line EoL-1 to investigate the molecular mechanisms regulating cyclin-dependent kinase inhibitor drug-induced apoptosis

AU - Alessandri, A. L.

AU - Hoodless, L.

AU - Lucas, Christopher

AU - Lyons, J. F.

AU - Haslett, C.

AU - Duffin, R.

AU - Rossi, A. G.

PY - 2012/9

Y1 - 2012/9

M3 - Meeting abstract

SN - 0019-2805

VL - 137

SP - 261

EP - 261

JO - Immunology

JF - Immunology

T2 - European Congress of Immunology

Y2 - 5 September 2012 through 8 September 2012

ER -